Spyglass Pharma, Inc. · NASDAQ:SGP
Vensana Capital I GP, LLC reported a 9.90% stake in Spyglass Pharma, Inc. (Schedule 13D)
Event Feb 9, 2026 · Filed Feb 10, 2026
Vensana Capital I GP, LLC reported a 9.90% stake in Spyglass Pharma, Inc., 3,310,619 shares, with active intent on Feb 9, 2026. Filed Feb 10, 2026 (Schedule 13D).
- Stake
- 9.90%
- Shares
- 3,310,619
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vensana Capital I GP, LLC | 9.90% | 3,310,619 |
| Vensana Capital I, L.P. | 9.90% | 3,310,619 |
| Kirk Nielsen | 9.90% | 3,312,141 |
| Peter Justin Klein | 9.90% | 3,310,619 |
Source
Related
- Spyglass Pharma, Inc.
- Vensana Capital I GP, LLC
- Spyglass Pharma, Inc. shareholders
- Schedule 13D · Ra Capital Management, L.P. · Feb 17, 2026
- Schedule 13G · Srinivas Akkaraju · Feb 17, 2026
- Schedule 13D · New Enterprise Associates 17, L.P. · Feb 13, 2026
- Schedule 13D · Gilde Healthcare Holding B.V. · Feb 13, 2026
- Schedule 13G · Sands Frank M. · Feb 13, 2026